Quick Answer
Mosaic ImmunoEngineering Inc. reported Diluted EPS of $0.13 per share (loss) for fiscal year 2024.
Mosaic ImmunoEngineering Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.13 | +7.1% |
| 2023 | -$0.14 | +57.6% |
| 2022 | -$0.33 | +40.0% |
| 2021 | -$0.55 | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | +33.3% | +0.0% |
| June 30, 2025 | -$0.02 | +50.0% | +33.3% |
| March 31, 2025 | -$0.03 | +25.0% | +0.0% |
| September 30, 2024 | -$0.03 | +40.0% | +25.0% |
| June 30, 2024 | -$0.04 | — | +0.0% |
| March 31, 2024 | -$0.04 | +33.3% | +20.0% |
| September 30, 2023 | -$0.05 | -150.0% | — |
| June 30, 2023 | $0.00 | +100.0% | +100.0% |
- Mosaic ImmunoEngineering Inc. showed an increase of +7.1% in Diluted EPS compared to the prior fiscal year.
- The most recent figure is from Mosaic ImmunoEngineering Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: